IFF (IFF) Appoints Frank Clyburn as CEO and Director
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St futures gain as AI, consulting stocks offset bond-market jitters
- Oil prices rise 2% as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- These 5 AI chip stocks are must-own into Q4, BofA says
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
IFF Appoints Frank Clyburn as Chief Executive Officer and Board Director; Separates Chairman and Chief Executive Officer Roles
January 20, 2022 6:50 AM ESTNEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board of Directors, effective February 14, 2022.
Mr. Clyburn joins IFF from Merck & Co. (Merck), where he currently serves as Executive Vice President and President of Human Health and today has full P&L responsibility for nearly 90% of Mercks $48 billion business. He brings extensive experience leading complex global businesses and executing with exceptional operating discipline. Mr. Clyburn has an in-depth... More
